S-Equol
The active soy metabolite that only about a third of people produce themselves. Supplementing it reduces hot flashes modestly, with the clearest signal in women who cannot make their own.
Where to buy
Ships to 180+ countries · welcome discount for new customers
Referral link — this site may earn a commission on purchases.
What the science says
- Hot flash frequency Moderate evidence
A systematic review and meta-analysis of randomized trials concluded that equol supplementation reduces hot flashes in postmenopausal women. The pooled effect is modest and rests on a small number of trials.
- Benefit concentrated in equol non-producers Limited evidence
A pilot study comparing S-equol with conventional soy isoflavones found the effect on hot flash frequency was most apparent in women who do not produce equol from soy themselves. This is a plausible but under-tested hypothesis.
Dosage & safety
How to take it
Interactions
With medications
- tamoxifen and aromatase inhibitors
S-equol is an estrogen receptor beta agonist and its effect alongside endocrine therapy is unstudied. do not use without your oncologist's agreement
With other supplements
- soy isoflavone supplements
Overlapping estrogen-receptor activity, with no reason to take both. pick one rather than stacking them
Well-established interactions only — this is not a complete list. Always tell your doctor and pharmacist what you take.
Frequently asked questions
Does S-equol help hot flashes?
Yes, modestly: a meta-analysis of randomized trials found equol supplementation reduces hot flashes in postmenopausal women, a moderate-grade finding based on a small number of trials.
Who benefits most from S-equol?
S-equol is aimed at people who cannot make equol from soy themselves, roughly half to two-thirds of people. A pilot study found the hot flash benefit was most apparent in these non-producers, but that idea is under-tested.
How much S-equol should I take?
Trials used 10-30 mg of S-equol daily, most often 10 mg once or twice a day for 8-12 weeks, with or without food.
Is S-equol safe after breast cancer?
S-equol is an estrogen receptor beta agonist, so women with hormone-sensitive breast cancer or on tamoxifen should not use it without their oncologist's agreement. Otherwise it was well tolerated in trials of up to a year, with mild digestive complaints most common.
Scientific references
Related in Women's health
- Folic Acid (Vitamin B9) Strong evidence
- Inositol (Myo-Inositol) Moderate evidence
- Strontium Limited evidence
- Soy Isoflavones Moderate evidence
- Ipriflavone Limited evidence
- Evening Primrose Oil Limited evidence